New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.
Groups of people doing communal exercises are an everyday sight in Japan, but for one woman they are a very public way to show she is fighting back.
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.